Comparative study of bulky stage IB and IIA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: Long-term follow-up

Journal of the Medical Association of Thailand

Volumn 84, Issue 11, 2001, Pages 1550-1557

  Manusirivithaya, Sumonmal ^a   Chareoniam, Viruch ^b   Pantusart, Aree ^c   Isariyodom, Pawares ^b   Srisomboon, Jatupol ^c  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b Kasemradht Hospital   (Thailand)

^c Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Cervical Cancer; Chemotherapy; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; RADICAL HYSTERECTOMY; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DOXORUBICIN; FEMALE; HUMANS; HYSTERECTOMY; METHOTREXATE; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VINBLASTINE;

EID: 0035735387     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Petterson F ed. Annual report on the results of treatment in gynecological cancer. Stockholm, 1991; 20: 1-8.
2. nd annual report on the results of treatment in gynecological cancer. Stockholm, FIGO, 1994; 22: 1-10.
3. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet 1997; 350: 535-40.
4. Roddick JR Jr, Greenlaw RH. Treatment of cervical cancer : A randomized study of operation and radiation. Am J Obstet Gynecol 1971; 109: 754-64.
5. Newton M. Radical hysterectomy or radiotherapy for stage I cervical cancer. A prospective comparison with five and ten year follow-up. Am J Obstet Gynecol 1975; 123: 535-43.
6. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasive). Am J Obstet Gynecol 1976; 126: 785-98.
7. Piver M, Chung W. Prognostic significance of cervical lesion size and pelvic node metastasis in cervical carcinoma. Obstet Gynecol 1975; 46: 507-10.
8. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical pathologic study of the disease free interval in patients with stage IB squamous cell cancer of the cervix. Gynecol Oncol 1990; 38: 352-7.
9. Benedetii-Panici P, Greggi S, Scambia G, et al. High-dose cisplatin and bleomycin neoadjuvant chemotherapy plus radical surgery in locally advanced cervicaal carcinoma. A preliminary report. Gynecol Oncol 1991; 41: 212-6.
10. Chang HC, Lai CH, Chou PC, et al. Neoadjuvant chemotherapy with cisplatin, vincristine and bleomycin and radical surgery in early staage bulky cervical carcinoma. Cancer Chemother Pharmacol 1992; 30: 281-5.
11. Dottino PR, Plaxe SC, Beddoe AM, et al. Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 1991; 40: 7-11.
12. Eddy GL, Manetta A, Alvarez RD, et al. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage Ib bulky cervical cancer: A Gynecologic Oncology Group pilot study. Gynecol Oncol 1995; 57: 412-6.
13. Fontanelli R, Spatti G, Raspagliesi F, et al. A prospective single course of high dose cisplatin and bleomycin with gluththion in bulky stage Ib/II carcinoma of the cervix. Ann Oncol 1992; 3: 117-21.
14. Sardi JE, Giaroli A, Sananes C, et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous cell carcinoma of the cervix. Gynecol Oncol 1997; 67: 61-9.
15. Namkoong SE, Park JS, Kim JW, et al. Comparative study of the patients with locally advanced stage I and II cervical cancer treated by radical surgery with and without pre-operative adjuvant chemotherapy. Gynecol Oncol 1995; 59: 136-42.
16. Serur E, Mathews RP, Gates J, et al. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix. Gynecol Oncol 1997; 65: 348-56.
17. Fuller AF Jr, Elliott N, Kosloff C, Hoskins WJ, Lewis JL Jr. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 1989; 33: 34-9.
18. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991; 77: 912-7.
19. Burke TW, Hoskins WJ, Heller PB, Bibro MC, Weiser EB, Park PC. Prognostic factors associated with radical hysterectomy failure. Gynecol Oncol 1987; 26: 153-9.
20. Larson DM, Copeland LJ, Stringer CA, Gershenson DM, Malone JM Jr. Edwards CL. Recurrent cervical carcinoma after radical hysterectomy. Gynecol Oncol 1988; 30: 381-7.
21. Chang T, Laai C, Hong J, et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 2000; 18: 1740-7.
22. Zaino RJ, Ward S, Delgado G, et al. Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study. Cancer 1992; 69: 1750-8.
23. Lai CH, Chang HC, Chang TC. Prognostic factors and impacts of adjuvant therapy in early stage cervical carcinoma with pelvic node metastases. Gynecol Oncol 1993; 51: 390-6.
24. Sevin BU, Nadji M, Lampe B, Lu Y. Prognostic factors of early stage cervical cancer treated by radical hysterectomy. Cancer 1995; 76 (Suppl): 1978-86.